Boosted darunavir plus lamivudine matches three-drug regimen
1136  

Boosted darunavir plus lamivudine matches three-drug regimen

A combination of darunavir/ritonavir and lamivudine was just as effective as the same combination plus tenofovir, according to 24-week results of the ANDES study presented last month by Professor Pedro Cahn at the 9th IAS Conference on HIV Science in Paris (IAS 2017). Darunavir boosted by ritonavir ...

09 августа, 2017
AIDSmap  
The Medicines Patent Pool Welcomes First Generic Dolutegravir-Combination to Receive Tentative Approval from U.S. Food and Drug Administration
955  

The Medicines Patent Pool Welcomes First Generic Dolutegravir-Combination to Receive Tentative Approval from U.S. Food and Drug Administration

The Medicines Patent Pool (MPP) welcomes its sublicensing partner Mylan’s announcement yesterday that it has received Tentative Approval from the U.S. Food and Drug Administration (USFDA) for generic versions of its combination product tenofovir disoproxil fumarate (TDF), lamivudine (3TC) and dolutegravir (DTG). Mylan signed a licence ...

08 августа, 2017